Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Neon Therapeutics, Inc. | 9,741,636 | reported | 29 Jun 2018 | tx 4+9,341,636−46,708,185 |
| CytomX Therapeutics, Inc. | 8,670,351 | reported | 14 Oct 2015 | tx 3+8,670,351−8,670,351 |
| Revolution Medicines, Inc. | 7,024,031 | reported | 02 Dec 2020 | tx 1−1,000,000 |
| Foundation Medicine, Inc. | 4,927,234 | reported | 12 May 2014 | tx 8+6,357,684−26,641,570 |
| Fulcrum Therapeutics, Inc. | 3,962,202 | reported | 10 Nov 2021 | tx 7+5,700,773−41,166,667 |
| Jounce Therapeutics, Inc. | 2,697,829 | reported | 15 Sept 2021 | tx 1−1,750,000 |
| MyoKardia Inc | 885,104 | reported | 07 Mar 2018 | tx 2−2,035,000 |
| Blueprint Medicines Corp | 116,444 | reported | 16 Mar 2017 | tx 3−1,230,000 |
| Eleven Biotherapeutics, Inc. | 16,143 | reported | 20 Mar 2014 | tx 1+16,143 |
| Voyager Therapeutics, Inc. | 15,000 | reported | 03 Jun 2021 | tx 12+10,678,235−49,670,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Nov 2021 | OTHER | Fulcrum Therapeutics, Inc. | 1,000,000 | — | |
| 22 Sept 2021 | OTHER | Fulcrum Therapeutics, Inc. | 1,000,000 | — | |
| 15 Sept 2021 | OTHER | Jounce Therapeutics, Inc. | 1,750,000 | — | |
| 09 Jun 2021 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 03 Jun 2021 | GRANT_AWARD | Voyager Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 02 Dec 2020 | OTHER | Revolution Medicines, Inc. | 1,000,000 | — | |
| 28 Jul 2020 | CONVERSION | Nurix Therapeutics, Inc. | 4,508,333 | — | |
| 28 Jul 2020 | CONVERSION | Nurix Therapeutics, Inc. | 875,000 | — | |
| 28 Jul 2020 | CONVERSION | Nurix Therapeutics, Inc. | 39,216 | — | |
| 28 Jul 2020 | CONVERSION | Nurix Therapeutics, Inc. | 875,000 | 0.00 USD | deriv |
| 28 Jul 2020 | CONVERSION | Nurix Therapeutics, Inc. | 4,508,333 | 0.00 USD | deriv |
| 28 Jul 2020 | CONVERSION | Nurix Therapeutics, Inc. | 39,216 | 0.00 USD | deriv |
| 20 Jul 2020 | CONVERSION | Relay Therapeutics, Inc. | 9,970,454 | 0.00 USD | |
| 20 Jul 2020 | CONVERSION | Relay Therapeutics, Inc. | 17,427 | 0.00 USD | |
| 20 Jul 2020 | CONVERSION | Relay Therapeutics, Inc. | 17,427 | 0.00 USD | |
| 20 Jul 2020 | CONVERSION | Relay Therapeutics, Inc. | 2,793,770 | 0.00 USD | |
| 20 Jul 2020 | CONVERSION | Relay Therapeutics, Inc. | 35,404,286 | — | deriv |
| 20 Jul 2020 | CONVERSION | Relay Therapeutics, Inc. | 9,920,455 | — | deriv |
| 20 Jul 2020 | CONVERSION | Relay Therapeutics, Inc. | 61,881 | — | deriv |
| 20 Jul 2020 | CONVERSION | Relay Therapeutics, Inc. | 61,881 | — | deriv |
| 11 Jun 2020 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 9,285 | 0.00 USD | deriv |
| 04 Jun 2020 | GRANT_AWARD | Voyager Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 22 Jul 2019 | CONVERSION | Fulcrum Therapeutics, Inc. | 5,595,238 | — | |
| 22 Jul 2019 | PURCHASE | Fulcrum Therapeutics, Inc. | 81,250 | 16.00 USD | |
| 22 Jul 2019 | CONVERSION | Fulcrum Therapeutics, Inc. | 39,166,667 | 0.00 USD | deriv |